Resona Asset Management Co. Ltd. Buys Shares of 15,689 HealthEquity, Inc. (NASDAQ:HQY)

Resona Asset Management Co. Ltd. bought a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, Holdings Channel.com reports. The fund bought 15,689 shares of the company’s stock, valued at approximately $1,505,000.

A number of other large investors have also modified their holdings of HQY. Smartleaf Asset Management LLC boosted its position in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after buying an additional 98 shares during the last quarter. Louisiana State Employees Retirement System lifted its holdings in HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after acquiring an additional 100 shares during the period. Oregon Public Employees Retirement Fund lifted its holdings in HealthEquity by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock valued at $1,706,000 after acquiring an additional 100 shares during the period. State of Michigan Retirement System lifted its holdings in HealthEquity by 0.5% in the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock valued at $1,988,000 after acquiring an additional 100 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in HealthEquity by 0.6% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company’s stock valued at $1,850,000 after acquiring an additional 106 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HQY. KeyCorp decreased their price target on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Monday, March 24th. Barrington Research reissued an “outperform” rating and issued a $112.00 price target on shares of HealthEquity in a report on Friday, March 14th. The Goldman Sachs Group decreased their price target on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a report on Thursday, March 27th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their target price for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $112.58.

HealthEquity Price Performance

HQY stock opened at $83.13 on Thursday. The business has a 50 day moving average price of $98.83 and a 200 day moving average price of $96.26. The stock has a market cap of $7.19 billion, a price-to-earnings ratio of 76.27, a PEG ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.